Effects on age-related phenotypes and on cardiovascular and renal diseases have been linked to activation of the calcium/calmodulin-dependent kinase kinase β (CamKKβ)-AMPK pathway as well as enhancement of AMPK activity through the LKB1/AMPK pathway [24]. This evidence concerns the gene CAMKK2 and kidney disorder.